Skip to main content
. 2015 Sep 14;12(2):301–307. doi: 10.1080/21645515.2015.1090071

Table 4.

Carriage of specific pneumococcal subtypes in children with cancer according to pneumococcal vaccination statusa

  Vaccinated with PCV7 (n = 58) Not vaccinated against pneumococcus (n = 216) OR (95% CI)b
Carriers of PCV13 serotypes 15 (25.9) 26 (12.0) 1.60 (0.68-3.73)
Number of PCV13 serotypes carried
1 6 (10.3) 13 (6.0) 0.91 (0.28-2.97)
≥2 9 (15.5) 13 (6.0) 2.30 (0.80-6.61)
Serotype carried
Positive for serotype 1 0 (0.0) 1 (0.5) NE
Positive for serotype 3 1 (1.7) 1 (0.5) 4.15 (0.09-183.0)
Positive for serotype 4 6 (10.3) 6 (2.8) 3.11 (0.77-12.49)
Positive for serotype 5 2 (3.4) 2 (0.9) 2.82 (0.30-26.92)
Positive for serotype 6A 1 (1.7) 0 (0.0) NE
Positive for serotype 6B 0 (0.0) 1 (0.5) NE
Positive for serotype 7F 0 (0.0) 1 (0.5) NE
Positive for serotype 9V 1 (1.7) 4 (1.8) 1.09 (0.09–13.68)
Positive for serotype 14 0 (0.0) 0 (0.0) NE
Positive for serotype 18C 0 (0.0) 0 (0.0) NE
Positive for serotype 19A 2 (3.4) 0 (0.0) NE
Positive for serotype 19F 14 (24.1) 25 (11.6) 1.43 (0.60–3.40)
Positive for serotype 23F 0 (0.0) 1 (0.5) NE
Carriers of non-PCV13 serotypes 4 (6.9) 7 (3.2) 2.06 (0.52–8.09)
a

Three subjects had missing information on pneumococcal vaccination.

b

ORs adjusted for age at enrollment, gender, siblings, parental smoking, disease phase, co-trimoxazole prophylaxis and diagnosis. For the analyses on single serotypes, the reference category is non-carrier of each corresponding serotype.

CI: confidence interval; NE: not estimable; OR: odds ratio; PCV7: 7-valent pneumococcal conjugate vaccine.